Archived Filings

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2013 generated more than $1.8 billion in annual revenue.

Investor Contact

Investor Relations Dept
Catalent Pharma Solutions
14 Schoolhouse Road
Somerset, NJ 08873

Phone 732 537 6325
Fax 732 537 5932
investors@catalent.com